156 related articles for article (PubMed ID: 29115530)
1. Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats.
Zhao NJ; Liao MJ; Wu JJ; Chu KX
Mol Med Rep; 2018 Jan; 17(1):819-826. PubMed ID: 29115530
[TBL] [Abstract][Full Text] [Related]
2. Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
Li HS
Ann Hepatol; 2018 Aug; 17(5):769-778. PubMed ID: 30145577
[TBL] [Abstract][Full Text] [Related]
3. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
[TBL] [Abstract][Full Text] [Related]
4. Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth.
Gu C; Zeng Y; Tang Z; Wang C; He Y; Feng X; Zhou L
Mol Med Rep; 2015 Nov; 12(5):6451-60. PubMed ID: 26323321
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
[TBL] [Abstract][Full Text] [Related]
6. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
Shen L; Liu Z; Gong J; Zhang L; Wang L; Magdalou J; Chen L; Wang H
Toxicol Appl Pharmacol; 2014 Jan; 274(2):263-73. PubMed ID: 24275070
[TBL] [Abstract][Full Text] [Related]
7. Curcumin attenuates insulin resistance and hepatic lipid accumulation in a rat model of intra-uterine growth restriction through insulin signalling pathway and sterol regulatory element binding proteins.
Niu Y; He J; Ahmad H; Wang C; Zhong X; Zhang L; Cui T; Zhang J; Wang T
Br J Nutr; 2019 Sep; 122(6):616-624. PubMed ID: 31237229
[TBL] [Abstract][Full Text] [Related]
8. Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation.
Song NJ; Yun UJ; Yang S; Wu C; Seo CR; Gwon AR; Baik SH; Choi Y; Choi BY; Bahn G; Kim S; Kwon SM; Park JS; Baek SH; Park TJ; Yoon K; Kim BJ; Mattson MP; Lee SJ; Jo DG; Park KW
Sci Rep; 2016 Jan; 6():19377. PubMed ID: 26786165
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and voluntary exercise attenuate cardiometabolic syndrome and hepatic steatosis in ovariectomized rats fed a high-fat high-fructose diet.
Buniam J; Chukijrungroat N; Khamphaya T; Weerachayaphorn J; Saengsirisuwan V
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E908-E921. PubMed ID: 30807216
[TBL] [Abstract][Full Text] [Related]
10. Curcumin supplementation regulates lipid metabolism in broiler chickens.
Xie Z; Shen G; Wang Y; Wu C
Poult Sci; 2019 Jan; 98(1):422-429. PubMed ID: 30053224
[TBL] [Abstract][Full Text] [Related]
11. Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.
Shi L; Shi L; Zhang H; Hu Z; Wang C; Zhang D; Song G
Mol Med Rep; 2013 Aug; 8(2):439-45. PubMed ID: 23754536
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.
Collison KS; Maqbool Z; Saleh SM; Inglis A; Makhoul NJ; Bakheet R; Al-Johi M; Al-Rabiah R; Zaidi MZ; Al-Mohanna FA
J Lipid Res; 2009 Aug; 50(8):1521-37. PubMed ID: 19001666
[TBL] [Abstract][Full Text] [Related]
13. Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease.
Li T; Yan H; Geng Y; Shi H; Li H; Wang S; Wang Y; Xu J; Zhao G; Lu X
Lipids Health Dis; 2019 Dec; 18(1):211. PubMed ID: 31805951
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
15. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
17. Preventive effect of curcumin on inflammation, oxidative stress and insulin resistance in high-fat fed obese rats.
Maithilikarpagaselvi N; Sridhar MG; Swaminathan RP; Sripradha R
J Complement Integr Med; 2016 Jun; 13(2):137-43. PubMed ID: 26845728
[TBL] [Abstract][Full Text] [Related]
18. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
[TBL] [Abstract][Full Text] [Related]
19. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
20. Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats.
Qi ZG; Zhao X; Zhong W; Xie ML
Pharm Biol; 2016; 54(5):882-8. PubMed ID: 26455539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
